Recombinant Human Asprosin (N-8His)

Artikelnummer: EBT-EPT172
Artikelname: Recombinant Human Asprosin (N-8His)
Artikelnummer: EBT-EPT172
Hersteller Artikelnummer: EPT172
Alternativnummer: EBT-EPT172-50
Hersteller: ELK Biotechnology
Kategorie: Proteine/Peptide
Alternative Synonym: Fibrillin-1, FBN1, Asprosin, FBN
Recombinant Human Asprosin is produced by our Mammalian expression system and the target gene encoding Ser2732-His2871 is expressed with a 8His tag at the N-terminus.
Molekulargewicht: Molecular weight: 17 KDa. Apparent molecular weight: 27-30 KDa, reducing conditions
UniProt: P35555
Reinheit: Greater than 95% as determined by reducing SDS-PAGE.
Anwendungsbeschreibung: Redissolve: Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100µg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.. Endotoxin: Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. Background: Asprosin is a protein hormone that is produced by white adipose tissue in mammals (and potentially by other tissues), which is then transported to the liver and stimulates it to release glucose into the blood stream. In the liver asprosin activates rapid glucose release by a cAMP-dependent pathway. The glucose release by the liver into the blood stream is vital for brain function and survival during fasting. People with neonatal progeroid syndrome lack asprosin, while people with insulin resistance have it in abundance. In animal tests asprosin showed potential for treating type 2 diabetes. When antibodies targeting asprosin were injected into diabetic mice, blood glucose and insulin levels improved